Disease and treatment characteristics of polycythemia vera patients in Belgium: Results from a scientific survey

Using cross-sectional data from patients with polycythemia vera (PV), Belgian researchers found that over 65% of patients with PV are still given hydroxyurea even though they may be resistant.

 European Journal of Haematology

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.